TSHA Taysha Gene Therapies Inc
Company Analysis
Latest News
🔴 Taysha Gene Therapies is trading 5% down; no verified catalyst identified
Taysha Gene Therapies is trading 5.24% lower at $3.79; no specific company announcement or verified catalyst was identified for the October 23, 2026...
🟢 Taysha Gene Therapies is trading 7.5% up in pre-market with no identified catalyst
Taysha Gene Therapies is trading at $4.31, up 7.52% in pre-market, with no specific catalyst identified. - No new company announcement dated October 23 was...
🟢 Taysha Gene Therapies is trading 6% up; no confirmed catalyst
Taysha Gene Therapies is trading at $4.17, up +5.96%, with no confirmed company-specific announcement explaining the October 20 move. - Taysha’s...
🟢 Taysha Gene Therapies is trading 5% up
Taysha Gene Therapies is trading 5.11% higher at $3.81 on October 19, with broader biotech strength providing supportive context; no company-specific catalyst...
🟢 Taysha Gene Therapies is trading 6.84% up today with no confirmed company-specific catalyst
Taysha Gene Therapies is trading 6.84% higher at $3.75, with no confirmed new company-specific announcement identified for October 15. - Previously announced...
🟢 Taysha Gene Therapies is trading 7.54% up in pre-market
Taysha Gene Therapies is trading at $3.85, up 7.54% in pre-market, with no clear company-specific catalyst identified. - The company’s latest listed releases...
🔴 Taysha Gene Therapies is trading 10.6% down today amid biotech-sector weakness
Taysha Gene Therapies is trading 10.6% lower at $3.70; no clear company-specific announcement explains the October 13 decline. - Its investor-relations...
🔴 Taysha Gene Therapies is trading 5.56% down today with biotech-sector weakness a possible factor
Taysha Gene Therapies is trading at $3.91, down 5.56%, with biotech-sector weakness a possible contributing factor. - No clear company-specific catalyst for...
🟢 Taysha Gene Therapies is trading 6.28% up in pre-market with no clear catalyst identified
Taysha Gene Therapies is trading at $4.40, up +6.28% pre-market on October 13, 2026, with no clear company-specific catalyst identified. - Shares closed at...
🔴 Taysha Gene Therapies is trading 5% down
Taysha Gene Therapies is trading 5.01% down at $4.26, with no clearly reported catalyst identified for the October 12 move. - No new company-specific...
🟢 Taysha Gene Therapies is trading 7% up in pre-market
Taysha Gene Therapies is trading 7% higher at $4.74 in pre-market on October 9, with no new company-specific announcement identified to explain the move. -...
🟢 Taysha Gene Therapies is trading 12.54% up in pre-market; catalyst remains unclear
Taysha Gene Therapies is trading at $4.94, up +12.54% in pre-market versus the October 6 close of $4.39. - No October 7 company-specific announcement...